Evidence map›Paper›PMID 18784345›Full record

ArticleJournal of leukocyte biology2008

Functional expression of IgA receptor FcalphaRI on human platelets.

Kun Qian, Fenglong Xie, Andrew W Gibson, Jeffrey C Edberg, Robert P Kimberly, Jianming Wu

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Thrombocytopenia in Sepsis.Life (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. FcαRI binding at the IgA1 CProceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  16. Review
  17. Article
  18. Review
  19. Anti-infective immunoadhesins from plants.Plant biotechnology journal · 2015
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kun QianDivision of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, 202 Shelby Interdisciplinary Biomedical Science Building, 1825 University Boulevard, Birmingham, AL 35294-2182, USA.
Fenglong Xie
Andrew W Gibson
Jeffrey C Edberg
Robert P Kimberly
Jianming Wu
University of Alabama at Birmingham · US

Funding

Zevalin Radioimmunotherapy Using a Modified TreatmentM01RR000032 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RICH, ROBERT R. · 1985 to 2008
$23.6M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI TIWARI, HEMANT K. · 2002 to 2012
$12.7M
ROS Modulation of Innate and Adaptive Immunity in RAP30AR048311 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MOUNTZ, JOHN D · 2001 to 2017
$9.5M
MONONUCLEAR PHAGOCYTE FUNCTION IN IMMUNOLOGIC DISEASESR01AR033062 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 1986 to 2010
$3.8M
SYSTEMIC VASCULITIS--HOST FACTORS IN TISSUE INJURYR01AR042476 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI EDBERG, JEFFREY C · 1994 to 2008
$2.4M
EXTRAMURAL RESEARCH FACILITIES CONTRUCTIONC06RR015490 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GERRITY, LAURETTA W · 2000 to 2000
$1.0M
POPULATION GENETICS ANALYSIS PROGRAM IMMUNITY TO VACCINES/INFECTION-266040068N01AI040068 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KASLOW, RICHARD ALAN · 2006 to 2006
–
NCRR NIH HHS C06 RR015490NCRR NIH HHS M01 RR000032NCRR NIH HHS M01-RR00032NIAID NIH HHS N01 AI040068NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P01-AR49084NIAMS NIH HHS P30 AR048311NIAMS NIH HHS P30-AR48311NIAMS NIH HHS R01 AR033062NIAMS NIH HHS R01 AR042476NIAMS NIH HHS R01-AR33062NIAMS NIH HHS R01-AR42476
6 · The paper itself

Abstract

FcalphaRI (CD89) is a human IgA FcR expressed on cells of myeloid lineage such as neutrophils, monocytes, tissue macrophages, eosinophils, and subpopulations of dendritic cells. FcalphaRI mediates cell activation through Src family kinases and downstream tyrosine-based phosphorylation pathways. However, the role of IgA and the expression and role of its cognate receptor FcalphaRI (CD89) in platelet activation are undefined. In the current study, we demonstrate that human platelets express FcalphaRI mRNAs and proteins. Furthermore, we show that the platelet FcalphaRI is associated with the FcR gamma-chain, and cross-linking of FcalphaRI leads to Syk phosphorylation. Clustering of FcalphaRI induces pre-mRNA splicing and protein production of tissue factor and IL-1beta, suggesting novel roles for human platelet FcalphaRI and serum IgA in thrombosis and inflammation.

Indexed as

Antigens, CDBlood PlateletsCross-Linking ReagentsFlow CytometryHumansImmunoblottingImmunoglobulin AImmunoprecipitationInterleukin-1betaIntracellular Signaling Peptides and ProteinsPhosphorylationPlatelet ActivationProtein-Tyrosine KinasesReceptors, FcReverse Transcriptase Polymerase Chain ReactionRNA, MessengerAntigens, CDCross-Linking ReagentsFc(alpha) receptorImmunoglobulin AInterleukin-1betaIntracellular Signaling Peptides and ProteinsProtein-Tyrosine KinasesReceptors, FcRNA, MessengerRNA PrecursorsSyk KinaseSYK protein, humanThromboplastin

Identifiers

PMID18784345
PMCPMC2614599
OpenAlexW2154054971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.